Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,875 USD | +14,31% | -0,65% | +41,67% |
11/04 | Sectorupdate: Gezondheidszorgaandelen eind van de middag zachter | MT |
11/04 | Top stijgers in de middag | MT |
Vakgebied
Aantal werknemers: 10
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Valerie Morisset
FOU | Founder | 55 | 18-10-18 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-18 |
Emily Pimblett
AUD | Comptroller/Controller/Auditor | 40 | 01-03-21 |
Joanne Palmer
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liam Ratcliffe
BRD | Director/Board Member | 60 | 01-10-19 |
Adam Rosenberg
BRD | Director/Board Member | 54 | 01-10-20 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-18 |
Simon Tate
BRD | Director/Board Member | 58 | 01-02-19 |
Judith Dunn
BRD | Director/Board Member | 62 | 01-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 043 268 | 20 718 241 ( 73,88 %) | 0 | 73,88 % |
Bedrijfsgegevens
Eliem Therapeutics, Inc.
2801 Centerville Road 1st Floor
19808-1609, Wilmington
+
http://www.eliemtx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,67% | 95,07 mln. | |
-1,94% | 103 mld. | |
+0,47% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,39% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-15,03% | 15,52 mld. | |
+3,46% | 13,86 mld. | |
+35,16% | 12,04 mld. |
- Beurs
- Aandelen
- Koers ELYM
- Onderneming Eliem Therapeutics, Inc.